Posted inMedical Technology
GE HealthCare, Philips, Siemens spotlight AI-forward imaging at RSNA 2025
Though artificial intelligence has long made a name for itself in imaging—with hundreds of programs able to automate separate steps…
Posted inMedical Technology
ARPA-H launches program to fund autonomous stroke-treating robots
The U.S. government’s Advanced Research Projects Agency for Health has launched a new funding program aimed at the development of…
Posted inMedical Technology
Hologic mammography studies show promise of AI in breast cancer detection
Hologic has put forward two studies of its artificial intelligence programs for mammography, showing that an AI tool could maintain…
Posted inMedical Technology
Ceribell scores FDA nod for detecting seizures in preterm newborns
In what Ceribell is hailing as a first of its kind, the company received a 510(k) clearance from the FDA…
Posted inMedical Technology
FTC outlines antitrust case against Edwards’ $945M JenaValve acquisition
The Federal Trade Commission (FTC) has begun outlining its case against Edwards Lifesciences' proposed purchase of heart implant developer JenaValve…
Posted inMedical Technology
GE HealthCare presents photon-counting CT system for FDA review
GE HealthCare is raising the curtain on its spearhead into the field of photon-counting CT, the Photonova Spectra, with an…
Posted inMedical Technology
J&J MedTech bolsters stroke R&D programs in Ireland
Johnson & Johnson MedTech is expanding its stroke-focused R&D in Ireland, building on previous investments and coming on the heels…
Posted inMedical Technology
Abbott to replace certain FreeStyle Libre 3 CGMs after incorrect readings and death reports
Abbott has launched an effort to replace some of its FreeStyle Libre 3 continuous glucose monitors—following reports of hundreds of…
Posted inMedical Technology
Solventum to buy Acera Surgical for up to $850M, repurchase $1B in stock
Solventum, which spun out of 3M nearly two years ago, will shell out up to $850 million for wound care…
Posted inMedical Technology
Roche inks $200M+ licensing pact for Freenome’s cancer screening blood tests
Roche has claimed the exclusive international rights to Freenome’s multiomic cancer screening approaches, toward the goal of developing blood testing…